YUYUE MEDICAL(SZ:002223) Sou Hu Cai Jing·2025-06-05 05:53Core Insights - The medical device market in China and globally is experiencing steady growth driven by technological advancements and increasing health management needs [1][3] - Yuyue Medical is committed to long-term strategies and expanding its global presence while solidifying its domestic market foundation [1][3] Financial Performance - In 2024, Yuyue Medical reported total revenue of 7.566 billion and a net profit of 1.806 billion, showcasing strong performance [3] - Key business segments generated significant revenue: respiratory treatment solutions at 2.597 billion, blood glucose management at 1.03 billion, and home health testing solutions at 1.564 billion [3] Business Development - Yuyue Medical is focusing on innovation in respiratory treatment products, enhancing stability, noise reduction, lightweight design, and smart technology [3][4] - The company is advancing its blood glucose management and POCT business with a focus on CGM products, achieving breakthroughs in clinical accuracy and smart management [4] - The home health testing segment is also growing, with new product developments like the S series atrial fibrillation blood pressure monitor [6] Global Expansion Strategy - Yuyue Medical is actively expanding its global market presence, with overseas revenue reaching 949 million, a year-on-year increase of 30.42% [6][7] - The company is establishing subsidiaries and offices in countries like Thailand and Germany to enhance local market engagement and operational efficiency [7] - In 2024, Yuyue Medical obtained 103 overseas registration certificates, facilitating its international business growth [7] Future Outlook - The company expresses confidence in its future growth, driven by strong performance in key sectors and a dual-circulation strategy [6][9] - Yuyue Medical aims to leverage technological breakthroughs and global healthcare demand to expand its reach and impact [9]